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IRF3 balances killing 
and cleaning
A clean house is a sign of a boring life. When 
more interesting or urgent matters arise, the 
housework has to wait. Similarly, when the 
body needs to fight infection, the liver’s clean-
up work is impaired. Chow et al. (page 2589) 
now show why: switching on virus-fighting 
factor interferon also switches off the liver’s 
detoxification pathway.
Viral infection can cause metabolic disorders, 
including cholesterol and bone metabolism 
defects as well as Reye’s syndrome, a defect in 
which aspirin becomes toxic because the liver 
fails to break it down. Liver detoxification is 
partly regulated by a transcription factor called 
retinoid X receptor (RXR), which turns on 
drug metabolism genes. But RXR is turned 
off by viral infection, Chow and colleagues 
now find.
RXR gets down-regulated by interferon reg-
ulatory factor 3 (IRF3), the same factor responsible 
for promoting virus-killing interferon expres-
sion as part of the primary immune response.
The team’s work reveals a mechanism for 
crosstalk between immunity and metabolism—
but why might cells need such crosstalk? 
“Fighting infection costs energy, and so does 
metabolism,” explains Chow. The simultaneous 
switching of resources in favor of the immune 
response and away from metabolism might 
thus be the body’s way of balancing the 
energy budget. 
Me, myself, and eye
The lack of just one self-antigen in the thymus can launch a tissue-specific 
autoimmune attack, report DeVoss et al. (page 2727).
T cells are taught which antigens to ignore as they develop in the thymus. 
Those whose antigen receptors recognize self-proteins are normally eliminated, 
preventing them from escaping into the circulation and later attacking self-
tissues. The transcription factor Aire (autoimmune regulator) drives the 
expression of many tissue-specific antigens in the thymus; without Aire, mice 
develop a panoply of autoimmune diseases. But so far no studies have proven 
the link between defects in Aire-induced expression of tissue antigens in the 
thymus and the development of autoimmunity against those tissues.
The team showed that one of the problems that crops up in aire−/− mice—
a spontaneous autoimmunity of the eye—is due to a T cell attack on an eye-
specific interphotoreceptor retinoid binding protein (IRBP). IRBP, the authors 
found, was expressed at a low level in the wild-type thymus, but was 
missing in the aire−/− thymus. 
Wild-type mice transplanted 
with thymi lacking IRBP 
developed the same eye 
disease, proving that the lack 
of thymic IRBP was solely 
responsible for the disorder.
Humans lacking Aire also 
develop retinopathy, although 
they more commonly develop 
other organ-specific 
autoimmune diseases. Given 
that aire−/− mice develop a 
range of tissue-specific 
autoimmune disorders, the 
authors plan to test whether 
those that are common to 
humans can also be pinned on 
the loss of a single antigen. 
Bedroom performance-boosting Viagra also 
boosts the immune system’s battle against cancer, 
report Serafini et al on page 2691.
In cancer patients, though the body gener-
ates tumor-specific antibodies, their efficacy is 
neutralized by the tumor itself. Tumors recruit 
cells such as myeloid-derived suppressor cells 
(MDSCs) and regulatory T cells, which suppress 
the body’s immune system, thus allowing the 
tumors to escape immune recognition. Borrello’s 
team has been investigating ways to overcome 
this immunosuppression.
Suppression of T cells by MDSCs requires, 
among other things, nitric oxide production. 
The team reasoned, therefore, that reducing 
nitric oxide levels might boost immunity in 
cancer patients. They thus turned to Viagra. 
Besides its well-known vasodilatory effect, 
Viagra also reduces nitric oxide production 
through a separate but linked pathway.
The team gave Viagra to mice with colon 
carcinoma and found that the immune systems 
of the mice were indeed boosted. The mice 
had an increased number of cytotoxic T cells, 
and tumor outgrowth was reduced by 50–70%. 
Viagra also provided a boost to T cells trans-
ferred to the mice using adoptive cell therapy, 
with tumor growth being reduced still further.
Viagra, either alone or in conjunction with 
transferred T cells, did not eradicate the tumors 
but did significantly slow their progression. Erad-
ication would require a full understanding of the 
multiple, complex pathways that lead to tumor-
induced immunosuppression. In the meantime, 
the immediate availability of Viagra means its 
potential clinical use can be readily tested. 
Tumor size in mice is reduced 
by Viagra treatments (right).
The lack of thymic IRBP creates autoantibodies 
(green) against retinal IRBP.
Raising more than just hope for cancer treatment